We Partner 4 Research | Clinical Trials In Washington DC, VA, MD
Show More

Your child can participate in this research study to help us understand the risk factors for heart disease in children with type 1 diabetes if:

  • Your child is between the ages of 12 - 21.

  • Your child is healthy OR has type 1 diabetes (for at least one year).

  • Your child is not taking medications that lower cholesterol or blood pressure.

  • You're willing to travel to MedStar Georgetown University Hospital (DC).

Interested? Enter your information to learn more!

Why are we doing this study?

Patients with type 1 diabetes are at a greater risk for future heart disease. We want to examine the role of risk factors on early heart disease in children with type 1 diabetes. Some of the risk factors include high cholesterol, poor control of diabetes and obesity.

There are medications available to help improve insulin resistance, weight gain and cholesterol. Some of the medications are used in adults with type 2 diabetes. What we want to know: Could we use these medications in the future to prevent heart disease in children with type 1 diabetes?

This study will help us learn more about the risk factors that contribute to heart disease that might potentially lead to new ways of treating patients with type 1 diabetes. Remember, your child can participate if he/she doesn't have diabetes.

What's involved in the study?

Those who enroll in the study will have one visit at Georgetown University that last about 2.5 hours. Participants will be compensated for their time ($75 or more). During the visit we will collect blood, body measurements and urine. Participants will also complete a questionnaire and undergo the following tests:

Heart disease & the connection to type 1 diabetes - Dr. Gourgari's interview w/ WUSA9

"If it helps with a good cause, it's what we're going for..." said Robbie Murphy, a 13-year-old who is helping Dr. Evgenia Gourgari, a pediatric endocrinologist, gather more information about heart attack risks in youth with Type 1 Diabetes. The study calls for more young volunteers with & without diabetes. 

"" This project was funded in whole or in part with federal funding (UL1TR00010101 previously UL1RR031975) from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, through the Clinical and Translational Science Awards Program (CTSA). , a trademark of DHHS, as part of the "Re-Engineering the Clinical Research Enterprise" project.